Your browser doesn't support javascript.
loading
Kinase Inhibitors: The Reality Behind the Success.
Jeon, Jae Yoon; Sparreboom, Alex; Baker, Sharyn D.
Afiliação
  • Jeon JY; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Sparreboom A; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Baker SD; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Clin Pharmacol Ther ; 102(5): 726-730, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28795397
ABSTRACT
Tremendous progress has been made by utilizing kinase inhibitors in oncology, and these agents continue to pave the way into other areas of medicine. There are, however, many challenges to the application of kinase inhibitors due to inherent shortcomings of the drugs and lack of comprehensive understanding of tumor and disease biology. The future fate of kinase inhibitors, however, is bright, as evidenced from ongoing efforts to increase their efficacy while remediating their weaknesses in order to provide the best quality of care to patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Neoplasias Limite: Animals / Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Neoplasias Limite: Animals / Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos